Filing Details

Accession Number:
0001104659-20-101370
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-01 16:05:32
Reporting Period:
2020-08-31
Accepted Time:
2020-09-01 16:05:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649904 Rhythm Pharmaceuticals Inc. RYTM Pharmaceutical Preparations (2834) 462159271
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1714105 Nithya Desikan 222 Berkeley Street, 12Th Floor
Boston MA 02116
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-31 25,000 $6.88 68,602 No 4 M Direct
Common Stock Disposition 2020-08-31 25,000 $30.00 43,602 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2020-08-31 25,000 $0.00 25,000 $6.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
97,961 2027-08-08 No 4 M Direct
Footnotes
  1. On August 31, 2020, Ms. Desikan exercised and sold 25,000 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018.